Zobrazeno 1 - 10
of 358
pro vyhledávání: '"Mary-Lou Smith"'
Publikováno v:
Frontiers in Human Neuroscience, Vol 14 (2021)
Working memory (WM) deficits are pervasive co-morbidities of epilepsy. Although the pathophysiological mechanisms underpinning these impairments remain elusive, it is thought that WM depends on oscillatory interactions within and between nodes of lar
Externí odkaz:
https://doaj.org/article/2634272483cd475bb4c2839d90216530
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-5 (2024)
Abstract The impact of knowledge of circulating tumor DNA (ctDNA) status on patient decisions in high-risk triple-negative breast cancer (TNBC) weighing benefit and toxicity is unknown. Here, 286 women with a history of non-metastatic breast cancer w
Externí odkaz:
https://doaj.org/article/06832c8dfd4f423b81a83fc9fc0b89c8
Autor:
Ciara C. O’Sullivan, Nicole L. Larson, Robert A. Vierkant, Mary Lou Smith, Cynthia Chauhan, Fergus J. Couch, Janet E. Olson, Charles L. Loprinzi, Kathryn J. Ruddy
Publikováno v:
Archives of Public Health, Vol 82, Iss 1, Pp 1-16 (2024)
Abstract Purpose The aims of the Advocate-BREAST project are to study and improve the breast cancer (BC) patient experience through education and patient-centered research. Methods In December 2021, an electronic REDCap survey was circulated to 6,918
Externí odkaz:
https://doaj.org/article/35f0f2fb820841898dc9f3870f5db4f6
Autor:
Imtiaz A Samjoo, Alexandra Hall, Connie Chen, Bao-Ngoc Nguye, Meaghan Bartlett, Mary Lou Smith, Nadia Harbeck, Joseph C Cappelleri, Meghan Karuturi, Doris Makari, Lillian Shahied Arruda, Rickard Sandin, Kent Hanson, Justin Doan
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 10 (2024)
Aim: To evaluate the impact of palbociclib treatment on health-related quality of life (HRQoL) in patients with hormone receptor-positive, human epidermal growth factor 2-negative advanced breast cancer (HR+/HER2- aBC) or metastatic breast cancer (
Externí odkaz:
https://doaj.org/article/f6f1b3a08af445aab4c5bd48f8bb6817
Autor:
Courtney Andrews, Timothy C. Childers, Kimberly D. Wiseman, Valerie Lawhon, Stacey Ingram, Mary Lou Smith, Antonio C. Wolff, Lynne Wagner, Gabrielle B. Rocque
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background As the combination of systemic and targeted chemotherapies is associated with severe adverse side effects and long-term health complications, there is interest in reducing treatment intensity for patients with early-stage breast c
Externí odkaz:
https://doaj.org/article/60989516780d47b5b91098c1e668634e
Autor:
Mary Lou Smith
Publikováno v:
Epilepsy & Behavior Reports, Vol 18, Iss , Pp 100515- (2022)
Memory deficits are commonly associated with temporal-lobe epilepsy. Memory may worsen after surgical resection of the temporal lobe. Risk factors for decline are structural integrity of the mesial temporal lobe structures and intact pre-operative me
Externí odkaz:
https://doaj.org/article/0e13e2d540144d70917d5011c47026ed
Autor:
Samantha Joplin, Michael Gascoigne, Belinda Barton, Richard Webster, Deepak Gill, John Lawson, Anna Mandalis, Mark Sabaz, Samantha McLean, Linda Gonzalez, Mary-Lou Smith, Suncica Lah
Publikováno v:
Child Neuropsychology. :1-19
Autor:
Julie Sato, Sarah I. Mossad, Simeon M. Wong, Benjamin A.E. Hunt, Benjamin T. Dunkley, Mary Lou Smith, Charline Urbain, Margot J. Taylor
Publikováno v:
Developmental Cognitive Neuroscience, Vol 34, Iss , Pp 114-123 (2018)
Working Memory (WM) supports a wide range of cognitive functions, and is positively associated with academic achievement. Although fMRI studies have revealed WM networks in adults, little is known about how these networks develop to support successfu
Externí odkaz:
https://doaj.org/article/5e2a75be0b49402ea1f61ba5e46c1ab6
Autor:
Gabrielle B. Rocque, Andrews Courtney, Rachel M. Frazier, Lawhon Valerie, Stacey A. Ingram, Mary Lou Smith, Lynne I. Wagner, Lisa Zubkoff, Nadine Tung, Lauren P. Wallner, Antonio C. Wolff
Publikováno v:
Cancer Research. 83:P6-09
Background: As outcomes improve in early-stage breast cancer, clinical trials are undergoing a paradigm shift from intensification trials (more therapy) to improve survival to optimization trials, which assess the potential for using less toxic thera
Autor:
Gabrielle B. Rocque, Courtney Andrews, Valerie M. Lawhon, Rachel Frazier, Stacey A. Ingram, Mary Lou Smith, Lynne I. Wagner, Lisa Zubkoff, Nadine Tung, Lauren P. Wallner, Antonio C. Wolff
Publikováno v:
JCO Oncology Practice. 19:e263-e273
PURPOSE: As outcomes improve in early-stage breast cancer, clinical trials are undergoing a paradigm shift from intensification trials (more therapy) to improve survival to optimization trials, which assess the potential for using less toxic therapy